GLP-1 drugs linked to lower kidney failure risk in bipolar disorder
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Americans are putting more additives—and calories—in their coffee
United Kingdom
-
Motor neurons activate unexpected defense to clear ALS-linked protein before it clumps
United Kingdom
-
Cranberry juice may be a boon for oral hygiene
United Kingdom
-
Stigmatizing patient details can push AI to deprioritize high-risk emergency cases
United Kingdom
-
New biological model proposes why postpartum vulvar pain persists after hormones recover
United Kingdom
-
Targeting lung cancer's cellular shipping system could offer a new way to slow tumor growth
United Kingdom
-
South Africa's HPV vaccination drive to protect girls from cervical cancer is working—what we know after 10 years
United Kingdom
-
Cell therapy using cardiac muscle cell aggregates improves heart function following a heart attack
United Kingdom